HeartBEATS from Lifelong Learning™
Jul 30, 2026 · 25 min · 11 segments
This video explores the evolving burden of shingle from epidemiology and clinical impact to risk factors and complications—while also looking ahead to how healthcare systems can shift toward more…
Karen LarmerHostAndrew HuangPanelist
Anthony VieiraPanelist
The first part of our discussion is going to focus on shifting from reactive to preventive care.
And I will start by asking Dr. Vieira, how do you see the management of shingles evolving from a reactive treatment-based model to a more proactive prevention first approach in the next five to 10 years?
The patient presents with the classic syndrome and the rash and then is given antivirals and pain control.
Over the next decade, shingles management will transition from an episodic treatment paradigm to a lifelong immune risk management strategy where vaccination, predictive analytics, and immune monitoring are used to prevent reactivation before it occurs.
We'll move from an age-based vaccination, for example, greater than or equal to 50 years or immunocompromised, to earlier vaccination based on risk, not just age.
Shingles prevention will increasingly align with goals of reducing post-herpetic neuralgia, functional decline, and downstream risks such as stroke and cognitive decline.
What do you think it would take to embed this shingles risk assessment into routine preventive care and these workflows across specialties?
Yeah, so embedding shingles risk assessment into routine preventive care across specialties will require elevating it from a guideline based recommendation to a system embedded clinical function that operates seamlessly across the care continuum.
I believe this needs to be built on a validated, easy to interpret risk model that translates directly into action.
and to integrate into our electronic health records as both a passive background calculation, as well as an active context specific prompt at key clinical moments, such as patient's annual visits or someone coming in for initiation of immunosuppressive therapy.
Together, primary care clinicians, specialists, and pharmacies are all supported by closed loop interoperability that ensures vaccination orders, administration, and documentation flow effortlessly, across settings.
And sustaining this will depend on reframing shingles as a predictable and preventable manifestation of immune decline, thereby normalizing its assessment alongside other chronic risk calculations like we do for atherosclerotic cardiovascular disease and reinforcing its role within broader healthy aging and immune resilience strategies.
The first part of our discussion is going to focus on shifting from reactive to preventive care.
And I will start by asking Dr. Vieira, how do you see the management of shingles evolving from a reactive treatment-based model to a more proactive prevention first approach in the next five to 10 years?
The patient presents with the classic syndrome and the rash and then is given antivirals and pain control.
Over the next decade, shingles management will transition from an episodic treatment paradigm to a lifelong immune risk management strategy where vaccination, predictive analytics, and immune monitoring are used to prevent reactivation before it occurs.
We'll move from an age-based vaccination, for example, greater than or equal to 50 years or immunocompromised, to earlier vaccination based on risk, not just age.
Shingles prevention will increasingly align with goals of reducing post-herpetic neuralgia, functional decline, and downstream risks such as stroke and cognitive decline.
What do you think it would take to embed this shingles risk assessment into routine preventive care and these workflows across specialties?
Yeah, so embedding shingles risk assessment into routine preventive care across specialties will require elevating it from a guideline based recommendation to a system embedded clinical function that operates seamlessly across the care continuum.
I believe this needs to be built on a validated, easy to interpret risk model that translates directly into action.
and to integrate into our electronic health records as both a passive background calculation, as well as an active context specific prompt at key clinical moments, such as patient's annual visits or someone coming in for initiation of immunosuppressive therapy.
Together, primary care clinicians, specialists, and pharmacies are all supported by closed loop interoperability that ensures vaccination orders, administration, and documentation flow effortlessly, across settings.
And sustaining this will depend on reframing shingles as a predictable and preventable manifestation of immune decline, thereby normalizing its assessment alongside other chronic risk calculations like we do for atherosclerotic cardiovascular disease and reinforcing its role within broader healthy aging and immune resilience strategies.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.